DrugPatentWatch Database Preview
Investigational Drug Information for Ketanserin
Email this page to a colleague
What is the development status for investigational drug Ketanserin?
Ketanserin is an investigational drug.
There have been 9 clinical trials for Ketanserin.
The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2011.
The most common disease conditions in clinical trials are Foot Ulcer, Diabetic Foot, and Shock, Septic. The leading clinical trial sponsors are University Hospital, Basel, Switzerland, Gitte Moos Knudsen, and Psychiatric University Hospital, Zurich.
Summary for Ketanserin
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 4,301 |
| WIPO Patent Applications | 1,040 |
| Japanese Patent Applications | 984 |
| Clinical Trial Progress | Phase 3 (2011-03-01) |
| Vendors | 78 |
Recent Clinical Trials for Ketanserin
| Title | Sponsor | Phase |
|---|---|---|
| Role of the Serotonin 5-HT2A Receptor in Mescaline-induced Altered States of Consciousness | University Hospital, Basel, Switzerland | Phase 1 |
| Effect of Ketanserin After LSD Administration | University Hospital, Basel, Switzerland | Phase 1 |
| Role of the Serotonin 5-HT2A Receptor in LSD-induced Altered States of Consciousness (LDR-Study) | Matthias Liechti | Early Phase 1 |
Clinical Trial Summary for Ketanserin
Top disease conditions for Ketanserin
Top clinical trial sponsors for Ketanserin
US Patents for Ketanserin
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
